Yoshimoto, T., Nagase, H., Ishida, T., Inoue J. and Nariuchi, H.
Induction of Interleukin-12 p40 transcript by CD40 ligation via activation of Nuclear Factor-κB.
Eur. J. Immunol. 27, 3461-3470. (1997)
Baba, M., Kikuchi, Y., Mori, S., Kimoto, H., Inui, S., Sakaguchi, N., Inoue, J., Yamamoto, T., Takemori, T., Howard, M. and Takatsu, K.
Mouse germinal center B cells with the xid mutation retain responsiveness to anti-mouse CD40 antibodies but diminish IL-5 responsiveness.
Int. Immunol. 9, 1463-1373. (1997)
Sowa, Y., Shiio, Y., Fujita, T., Matsumoto, T., Okuyama, Y., Kato, D., Inoue, J., Sawada, J., Goto, M., Watanabe, H., Handa, H. and Sakai, T.
Retinoblastoma binding factor 1 site in the core promoter of the human Rb gene is activated by hGABP/EFTF1.
Cancer Research 57, 3145-3148. (1997)
Nishiyama-Fujimoto, A., Ishii, S., Matsuda, S., Inoue, J. and Yamamoto, T.
A novel zinc finger proteins Finb is a transcriptional activator and localized in nuclear bodies.
Gene 195, 267-275. (1997)
Aizawa, S., Nakano, H., Ishida, T., Horie, R., Nagai, M., Yagita H., Okumura, K., Inoue, J. and Watanabe, T.
TRAF5 and TRAF2 are involved in CD30 mediated NFκB activation.
J. Biol. Chem. 272, 2042-2045. (1997)
Otsuka, M., Fujita, M., Sugiura, Y., Yamamoto, T., Inoue, J., Maekawa, T. and Ishii, S.
Synthetic inhibitors of regulatory proteins involved in the signaling pathways of the replication of human immunodeficiency virus 1.
Bioorg. Med. Chem., 5, 205-215. (1997)
Sakamoto, Y., Yoshida, M., Semba, K., and Hunter, T.
Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase- mediated phosphorylation of Ser-365 and
Ser-393 in the zinc finger domain.
Oncogene 15, 2001-2012. (1997)
Kuramochi, S., Moriguchi, T., Kuida, K., Endo, J., Semba, K., Nishida, E., and Karasuyama, H.
LOK is a novel mouse STE20-like protein kinase that is expressed predominantly in lymphocytes.
J Biol Chem. 272, 22679-22684. (1997)
Moriyama, M., Yamochi, T., Semba, K., Akiyama, T., and Mori, S.
BCL-6 is phosphorylated at multiple sites in its serine- and proline- clustered region by mitogen-activated protein kinase (MAPK) in vivo.
Oncogene 14, 2465-2474. (1997)
Ojwang, J. O., Mustain, S. D., Marshall, H. B., Rao, T. S., Chaudhary, N., Walker, D. A., Hogan, M. E., Akiyama, T., Revankar, G. R., Peyman, A., Uhlmann, E., and Rando, R. F.
Modified antisense oligonucleotides directed against tumor necrosis factor receptor type I inhibit tumor necrosis factor α-mediated functions.
Biochemistry 36, 6033-6045. (1997)
Akiyama, T. and Hogan, M.E.
Structural analysis of DNA bending induced by ththered triple helix forming oligonucleotides.
Biochemistry 36, 2307-2315. (1997)
Ojwang, J. O., Lewis, A. F., Revankar, G. R., Walker, D., Akiyama. T., Hogan, M. E., and Rando, R. F.
Sequence-specific inhibition of the tumor necrosis factor-α receptor I gene by oligodeoxynucleotides containing N7 modified 2’-deoxyguanosine.
Antisense Nucleic Acid Drug Dev. 7, 447-459. (1997)